CLOs on the Move

Faculty Commons

www.clm.org

 
Faculty Commons is a Addison, TX-based company in the Business Services sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.clm.org

  • Addison, TX USA 75001
  • Phone: 972.713.7130

Executives

Name Title Contact Details

Similar Companies

National Sanitizer Inc

National Sanitizer Inc is a Huntsville, AL-based company in the Business Services sector.

Chu Vision Institute

Chu Vision Institute is a Minneapolis, MN-based company in the Business Services sector.

ACLU of Missouri

The American Civil Liberties Union of Missouri (ACLU-MO) is a non-partisan, not-for-profit, membership organization dedicated to the preservation and promotion of civil liberties in Missouri. With offices in both Kansas City and St. Louis, ACLU-MO is an affiliate of the national ACLU. The ACLU will always be on the side of fairness, equality, and justice – for all. Join us.

Ccfs Concrete Testing And Flooring Inspections

Ccfs Concrete Testing And Flooring Inspections is a Atlanta, GA-based company in the Business Services sector.

CARB-X

CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria. CARB-X is led by Boston University and its funding is provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services; the Wellcome Trust, a global charity based in the UK; Germanys Federal Ministry of Education and Research (BMBF); the UK Department of Health and Social Cares Global Antimicrobial Resistance Innovation Fund (UK GAMRIF); the Bill & Melinda Gates Foundation, and with in-kind support from National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH) within the HHS. CARB-X is investing more than $500 million from 2016-2021 to support innovative antibiotics and other therapeutics, vaccines and rapid diagnostics. CARB-X supports the worlds largest and most innovative pipeline of preclinical products against drug-resistant infections. CARB-X focuses exclusively on high priority drug-resistant bacteria, especially Gram-negatives. CARB-X is headquartered at Boston University School of Law.